Table 5.

Treatment outcomes in patients between group I and group II at 10 weeks

	Group I (AmB+	Group II (AmB+	P-value
	Fluconazole + 5-FC,n = 27)	Fluconazole + 5-FC + VPS, n = 39)
Lost to follow-up	0 (0.0%)	1 (2.3%)	0.399
Successful response	8 (29.6%)	22 (57.9%)	0.025*
Complete response	3 (11.1%)	11 (28.9%)
Partial response	5 (18.5%)	11 (28.9%)
Failure	19 (70.4%)	16 (42.1%)	0.350
Stable response	15 (55.6%)	10 (26.3%)
Disease progression	4 (14.8%)	4 (10.5%)
Death	0 (0.0%)	2 (5.3%)

^*p < 0.05